Tech & Science
The U.S. Food and Drug Administration (FDA) on Monday warned of an increased risk of Guillain-Barre (GBS), a rare neurological disorder.
Hi, what are you looking for?
The U.S. Food and Drug Administration (FDA) on Monday warned of an increased risk of Guillain-Barre (GBS), a rare neurological disorder.
In a Securities and Exchange Commission filing on Monday, Emergent said it “agreed not to initiate the manufacturing of any new material” for Johnson...
The FDA, along with the CDC and the Southern Nevada Health District is investigating a number of reports of acute non-viral hepatitis in the...
This latest report examined baby foods made by Nurture Inc, Hain Celestial Group Inc, Beech-Nut Nutrition, and Gerber. The report also noted that Walmart...
The Pfizer-BioNTech Covid-19 vaccine will reach hospitals and other sites across the United States by Monday morning, a top official said Saturday, ready to...
The two-dose vaccine is also the first to run the gauntlet of clinical studies, including Phase 3 trials usually required for approval. Russia and...
In the latest recall due to an outbreak of E. coli O157:H7 infections, Michigan-based Tanimura & Antle Inc. is voluntarily recalling its packaged single...
In what is probably the first of many meetings, the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC, met...
Last week, according to Digital Journal, Eli Lilly said that the National Institute of Allergy and Infectious Diseases paused a phase three government-backed clinical...
A senior administration official said the main issue regarding the FDA’s new guidelines for Emergency use Authorization (EUA) is the agency’s planned instruction that...